» Articles » PMID: 30249283

Inflammation: the Link Between Comorbidities, Genetics, and Alzheimer's Disease

Overview
Publisher Biomed Central
Date 2018 Sep 26
PMID 30249283
Citations 240
Authors
Affiliations
Soon will be listed here.
Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder, most cases of which lack a clear causative event. This has made the disease difficult to characterize and, thus, diagnose. Although some cases are genetically linked, there are many diseases and lifestyle factors that can lead to an increased risk of developing AD, including traumatic brain injury, diabetes, hypertension, obesity, and other metabolic syndromes, in addition to aging. Identifying common factors and trends between these conditions could enhance our understanding of AD and lead to the development of more effective treatments. Although the immune system is one of the body's key defense mechanisms, chronic inflammation has been increasingly linked with several age-related diseases. Moreover, it is now well accepted that chronic inflammation has an important role in the onset and progression of AD. In this review, the different inflammatory signals associated with AD and its risk factors will be outlined to demonstrate how chronic inflammation may be influencing individual susceptibility to AD. Our goal is to bring attention to potential shared signals presented by the immune system during different conditions that could lead to the development of successful treatments.

Citing Articles

Novel donepezil-tacrine hybrid (TAHB3) induces neurodifferentiation, neuroprotective effects, and activates the PI3K/AKT pathway on PC12 cells.

Dos Santos Ono R, Dos Santos Moreira N, Carvalho I, Passos G, Sakamoto-Hojo E J Alzheimers Dis Rep. 2025; 9:25424823241309268.

PMID: 40034521 PMC: 11864261. DOI: 10.1177/25424823241309268.


Neurodegenerative diseases and neuroinflammation-induced apoptosis.

Huang S, Lu Y, Fang W, Huang Y, Li Q, Xu Z Open Life Sci. 2025; 20(1):20221051.

PMID: 40026360 PMC: 11868719. DOI: 10.1515/biol-2022-1051.


Plasma proteomics for cognitive decline and dementia-A Southeast Asian cohort study.

Sim M, Doecke J, Liew O, Wong L, Tan E, Chan S Alzheimers Dement. 2025; 21(2):e14577.

PMID: 39998981 PMC: 11854348. DOI: 10.1002/alz.14577.


Methionine Aminopeptidase 2 (MetAP2) Inhibitor BL6 Attenuates Inflammation in Cultured Microglia and in a Mouse Model of Alzheimer's Disease.

Zhang X, Subbanna S, Williams C, Canals-Baker S, Hashim A, Wilson D Molecules. 2025; 30(3).

PMID: 39942725 PMC: 11820257. DOI: 10.3390/molecules30030620.


Bioinformatics approach reveals the critical role of inflammation-related genes in age-related hearing loss.

Gu X, Chen C, Chen Y, Zeng C, Lin Y, Guo R Sci Rep. 2025; 15(1):2687.

PMID: 39837906 PMC: 11751394. DOI: 10.1038/s41598-024-83428-x.


References
1.
Hellstrom-Lindahl E, Ravid R, Nordberg A . Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels. Neurobiol Aging. 2006; 29(2):210-21. DOI: 10.1016/j.neurobiolaging.2006.10.010. View

2.
Naj A, Jun G, Beecham G, Wang L, Vardarajan B, Buros J . Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011; 43(5):436-41. PMC: 3090745. DOI: 10.1038/ng.801. View

3.
Cao J, El Gaamouch F, Meabon J, Meeker K, Zhu L, Zhong M . ApoE4-associated phospholipid dysregulation contributes to development of Tau hyper-phosphorylation after traumatic brain injury. Sci Rep. 2017; 7(1):11372. PMC: 5595858. DOI: 10.1038/s41598-017-11654-7. View

4.
Fu Y, Hsiao J, Paxinos G, Halliday G, Kim W . ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain. J Alzheimers Dis. 2016; 54(2):569-84. DOI: 10.3233/JAD-160456. View

5.
Walker D, Whetzel A, Serrano G, Sue L, Beach T, Lue L . Association of CD33 polymorphism rs3865444 with Alzheimer's disease pathology and CD33 expression in human cerebral cortex. Neurobiol Aging. 2014; 36(2):571-82. PMC: 4315751. DOI: 10.1016/j.neurobiolaging.2014.09.023. View